Despite COPD being considered a chronic airway inflammatory disease predominantly driven by neutrophils and CD8 +T lymphocytes, 20–40% of patients also exhibit eosinophilic airway inflammation, which predisposes them to a better response to corticosteroids, but also to increased ECOPD risk [80,81]. This evidence concerns the gene CD8A and chronic obstructive pulmonary disease.